Navigation Links
Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016
Date:1/13/2011

SEATTLE, Jan. 13, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced its intention to offer, subject to market and other conditions, $500 million aggregate principal amount of convertible senior notes due January 15, 2016 (the "Notes") in an offering registered under the Securities Act of 1933, as amended (the "Securities Act").  The Notes will be convertible into cash, shares of Dendreon's common stock (the "Common Stock") or a combination of cash and shares of Common Stock, at Dendreon's election.  Dendreon also expects to grant the underwriter of the offering of the Notes an option to purchase up to an additional $75 million aggregate principal amount of Notes solely to cover overallotments.

The Notes will be the unsecured, senior obligations of Dendreon.  Interest on the Notes will be payable semi-annually in arrears on January 15 and July 15 of each year, beginning on July 15, 2011.  The interest rate, conversion rate, offering price and certain other terms of the Notes will be determined by negotiations between the company and the underwriter.  

Dendreon intends to use the net proceeds of the offering of the Notes to fund the continued investment in and expansion of its manufacturing facilities, including the construction of a new immunotherapy manufacturing facility in Europe and the expenses associated with increasing capacity at its existing Morris Plains, New Jersey, Atlanta, Georgia and Orange County, California facilities; cover expenses in connection with pursuing non-U.S. marketing approvals for PROVENGE® (sipuleucel-T); fund new clinical trials for PROVENGE and other product candidates; finance its marketing and awareness efforts for PROVENGE; fund the ongoing hiring of additional manufacturing, sales and marketing, quality, research and development and other personnel to support PROVENGE and its other
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
2. Dendreon Announces Presentation of PROVENGE Data at the American Society of Hematology and the Society of Urologic Oncology Annual Meetings
3. Dendreon Announces Webcast Presentation at Credit Suisse 2010 Health Care Conference
4. Dendreon Reports Third Quarter 2010 Financial Results
5. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
6. Dendreon Statement on CMS National Coverage Analysis
7. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
8. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
9. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
10. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
11. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 A medical ... use both in space and on Earth was inducted ... The technology assures high quality, secure handling ... low-power ultrasound units, like those used in hospitals and ... the diagnostic imaging solution of choice for human space ...
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
Breaking Medicine Technology:Wyle Aided System Gets Named to Space Technology Hall of Fame 2Wyle Aided System Gets Named to Space Technology Hall of Fame 3Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2
(Date:5/21/2013)... IL (PRWEB) May 21, 2013 The ... on the site for patients taking the blood thinner ... may be at more risk of death when suffering ... DrugRisks was created to improve the safety of patients ... recalls, studies and legal news. Visitors can see if ...
(Date:5/21/2013)... Limited mobility affects people in ways that the ... difficult to walk around, but everyday tasks like getting up ... of medical products made to assist those who need a ... seat. , Raised toilet seats keep users further ... or sit down. They come in a variety of sizes ...
(Date:5/20/2013)... was significantly associated with higher hyperactivity scores at ... University of Cincinnati (UC) and Cincinnati Children,s Hospital ... a study being published Tuesday, May 21, in ... access journal published by the National Institute of ... Institutes of Health (NIH). , The research ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 The ... product type into two categories - semi-automated and ... is classified into five categories, namely, hospitals, pre-hospital, ... is forecast till 2017. Automated external defibrillators play ... sudden cardiac arrest victims. Considering the life-saving potential ...
(Date:5/20/2013)... 2013 When people have ... to become a celebrity. New Jersey governor Chris ... News report (“Chris Christie Says Lap Band Surgery ... the surgery was not done so that he ... status as a former lap band patient. Simply ...
Breaking Medicine News(10 mins):Health News:DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Early-life traffic-related air pollution exposure linked to hyperactivity 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3
... carcinoma (HCC) patients in China may be treated with ... doubt its effectiveness. These stated that a research group ... of PTEN in HCC, which may suppress tumor cell ... A research article published on January 7, 2008 ...
... A procedure called carotid artery stenting (CAS) has ... carotid endarterectomy (CEA), for patients with dangerous narrowing of ... questions remain about the best uses of this procedureespecially ... "low-risk" patients, according to a special article in the ...
... 2008A research team from Universit Lavals Faculty of Medicine ... by the use of antipsychotic drugswhich in extreme cases ... one monthcan be avoided through a specially designed weight ... and kinesiologist Angelo Tremblay report the details of their ...
... team of Tchernev and Petrova from Alexandrovska Hospital in ... by chronic Hepatitis C virus (HCV). They were intrigued ... on the lower limbs, acute pain in the joints, ... They were also intrigued by the presence of cryoglobulins ...
... digestive enzyme specifically produced in the gastric mucosa. Human ... immunological properties, PGI and PGII. Serum PG levels seem ... in the stomach, and used as "serological biopsy." In ... on the identification of individuals for intervention studies, whereas ...
... for treatment of patients with chronic hepatitis B ... leads to the emergence of lamivudine-resistant hepatitis B ... with HBV. Sensitive methods for early detection of ... in treating patients with HBV infection. , To ...
Cached Medicine News:Health News:How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma? 2Health News:Vascular surgeons ask, what's next for carotid artery stenting? 2Health News:Weight gain induced by antipsychotic drugs can be avoided 2Health News:Attention: Extra-hepatic manifestation of hepatitis C virus infection 2Health News:What are the essential characteristics of serum PG in Chinese? 2Health News:What is the more suitable for early detection of low abundant lamivudine-resistant mutants? 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: